Neoadjuvant therapy for squamous cell carcinoma of the esophagus;Neoadjuvante therapie von plattenepithelkarzinomen des ösophagus: Was ist "evidence based"?

Chirurg

Volumn 76, Issue 11, 2005, Pages 1025-1032

  Lordick, F ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Esophagus; Neoadjuvant; Squamous cell cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER INVASION; CANCER STAGING; ESOPHAGUS; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; EVIDENCE BASED MEDICINE; HUMAN; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHASE 3 CLINICAL TRIAL; PROGNOSIS; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS, PHASE III; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGUS; EVIDENCE-BASED MEDICINE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE;

EID: 27844589338     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-005-1098-7     Document Type: Article

References (69)

1. Stein HJ, Siewert JR (2004) Improved prognosis of resected esophageal cancer. World J Surg 28: 520
2. Stein HJ, Lordick F, Siewert JR (2004) Ösophaguskarzinom. Chirurgische und multimodale Therapie. Chir Gastroenterol 20: 13
3. Stein HJ, von Rahden BH, Siewert JR (2005) Survival after oesophagectomy for cancer of the oesophagus. Langenbecks Arch Surg 390: 280-285
4. Urba SG, Orringer MB, Turrisi A, Iannettoni M et al. (2001) Randomized trial of preoperative chemoradiation vs. surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19: 305
5. Ancona E, Ruol A, Santi S et al. (2001) Only pathologically complete response to neoadjuvant chemotherapy improves significantly the long-term survival of patients with resectable esophageal squamous cell carcinoma: Final report of a randomized controlled trial of preoperative chemotherapy vs. surgery alone. Cancer 91: 2165
6. Ando N, Iizuka T, Ide H et al. (2003) Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study - JCOG9204. J Clin Oncol 21: 4592
7. Xiao ZF, Yang ZY, Liang J et al. (2003) Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg 75: 331
8. Law S, Kwong DL, Kwok KF et al. (2003) Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg 238: 339
9. Hofstetter W, Swisher SG, Correa AM et al. (2002) Treatment outcomes of resected esophageal cancer. Ann Surg 236: 376
10. Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Katajima M (2000) Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232: 225
11. Stahl M, Stuschke M, Lehmann N et al. (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23: 2310
12. Lee SJ, Lee KS, Yim YJ et al. (2005) Recurrence of squamous cell carcinoma of the oesophagus after curative surgery: rates and patterns on imaging studies correlated with tumour location and pathological stages. Clin Radiol 60: 547
13. Herskovic A, Martz K, al-Sarraf M et al. (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326: 1593
14. Rebecca WO, Richard MA (2003) Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev (2): CD002092
15. Fok M, McShane J, Law SYK et al. (1994) Prospective randomised study in the treatment of oesophageal carcinoma. Asian J Surg 17: 223
16. Launois B, Delarue D, Campion JP, Kerbaol M (1981) Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 153: 690
17. Gignoux M, Roussel A, Paillot B et al. (1987) The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C. World J Surg 11: 426
18. Wang M, Gu XZ, Yin W et al. (1989) Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int J Radiat Oncol Biol Phys 16: 325
19. Nygaard K, Hagen S, Hansen HS et al. (1992) Preoperative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 16: 1104
20. Arnott SJ, Duncan W, Kerr GR et al. (1992) Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. Radiother Oncol 24: 108
21. Arnott SJ, Duncan W, Gignoux M et al. (2000) Preoperative radiotherapy for esophageal carcinoma. Cochrane Database Syst Rev (4): DC001799
22. Roth JA, Pass HI, Flanagan MM et al. (1988) Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 96: 242
23. Schlag PM (1992) Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft fuer Onkologie der Deutschen Gesellschaft fuer Chirurgie Study Group. Arch Surg 127: 1446
24. Maipang T, Vasinanukorn P, Petpichetchian C et al. (1994) Induction chemotherapy in the treatment of patients with carcinoma of the esophagus. J Surg Oncol 56: 191
25. Law S, Fok M, Chow S, Chu KM, Wong J (1997) Preoperative chemotherapy vs. surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 114: 210
26. Kok TC, van Lanschot J, Siersema PD et al. (1997) Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: final report of a phase III multicenter randomized controlled trial [abstract]. Proc Ann Meet Am Soc Clin Oncol 16: 277a
27. Kelsen DP, Ginsberg R, Pajak TF et al. (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339: 1979
28. Medical Research Council Oesophageal Cancer Working Party (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet 359: 1727
29. Urschel JD, Vasan H, Blewett CJ (2002) A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am J Surg 183: 274
30. Malthaner R, Fenlon D (2003) Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev (4) CD001556
31. Le Prise E, Etienne PL, Meunier B et al. (1994) A randomized study of chemotherapy, radiation therapy, and surgery vs. surgery for localized squamous cell carcinoma of the esophagus. Cancer 73: 1779
32. Apinop C, Puttisak P, Preecha N (1994) A prospective study of combined therapy in esophageal cancer. Hepatol Gastroenterol 41: 391
33. Bosset JF, Gignoux M, Triboulet JP et al. (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337: 161
34. Walsh TN, McDonell CO, Mulligan ED et al. (2000) Multimodal therapy vs. surgery alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. Gastroenterology 118: A1008
35. Burmeister BH, Smithers BM, Fitzgerald L et al. (2002) A randomized phase III trial of preoperative chemoradiation followed by surgery (CR-S) vs. surgery alone (S) for localized resectable cancer of the esophagus. Proc Annu Meet Am Soc Clin Oncol 21: 130 [Abstr 518]
36. Lee JL, Park SI, Kim SB et al. (2004) A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery vs. surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 15: 947
37. Urschel JD, Vasan H (2003) A meta-analysis of ranomised controlled trials that compared neoadjuavnt chemoradiation and surgery alone for resectable esophageal cancer. Am J Surg 185: 538
38. Fiorica F, Di Bona D, Schepis F et al. (2004) Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 53: 925
39. Greer SE, Goodney PP, Sutton JE, Birkmeyer JD (2005) Neoadjuvant chemoradiation for esophageal carcinoma: A meta-analysis. Surgery 137: 172
40. Lightdale CJ, Kulkarni KG (2005) Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer. J Clin Oncol 23: 4483
41. Riedel M, Hauck RW, Stein HJ et al. (1998) Preoperative bronchoscopic assessment of airway invasion by esophageal cancer. Chest 113: 687
42. Iizuka T, Isono K, Kakegawa T, Waranabe H (1989) Parameters linked to ten-year survival in Japan of resected esophageal carcinoma. Japanese Committee for Registration of Esophageal carcinoma Cases. Chest 96: 1005
43. Roder JD, Busch R, Stein HJ, Fink U, Siewert JR (1994) Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 81: 410
44. Rösch T (1995) Endosonographic staging of esophageal cancer: a review of literature results. Gastrointest Endosc Clin N Am 5: 537
45. 18F-Fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 22: 3805
46. Bartels H, Stein HJ, Siewert JR (1998) Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 85: 840
47. Abou-Jawde JM, Mekhail T, Adelstein DJ et al. (2005) Impact of induction concurrent chemoradiotherapy on pulmonary function and postoperative acute respiratory complications in esophageal cancer. Chest 128: 250
48. Heidecke CD, Weighardt H, Feith M et al. (2002) Neoadjuvant treatment of the esophageal cancer: Immunosuppression following combined radiochemotherapy. Surgery 132: 495
49. Stein HJ, Bartels H, Siewert JR (2001) Esophageal cancer: indications for two-stage procedures. Chirurg 72: 881
50. Blazeby JM, Sanford E, Falk SJ, Alderson D, Donovan JL (2004) Health-related quality of life during neoadjuvant treatment and surgery for licalized esophageal carcinoma. Cancer 103: 1791
51. Khushalani NI, Leichman CG, Proulx G et al. (2002) Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer. J Clin Oncol 20: 2844
52. Brenner B, Ilson DH, Minsky BD (2004) Treatment of localized esophageal cancer. Sem Oncol 31: 554
53. Brenner B, Ilson DH, Minsky BD et al. (2004) Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuos-infusion paclitaxel with cisplatin and concurrent radiation therapy. J Clin Oncol 22: 45
54. Ilson DH, Bains M, Kelsen DP et al. (2003) Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer. J Clin Oncol 21: 2962
55. Mehta V (2005) Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: Pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys 63: 5
56. Berger AC, Farma J, Scott WJ et al. (2005) Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 23: 4330
57. Brucher BL, Stein HJ, Zimmermann F et al. (2004) Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial. Eur J Surg Oncol 30: 963
58. Rizk NP, Bains MS, Ilson DH, Minsky B, Rusch VW (2005) The AJCC staging system does not predict survival in patients receiving multimodality therapy for esophageal cancer. Proc Am Soc Clin Oncol: abstract 4005
59. Swisher SG, Hofstetter W, Wu TT et al. (2005) Proposed revision of the esophageal cancer staging system to accommodate pathologic response following preoperative chemoradiation (CRT). Ann Surg 241: 810
60. Jones DR, Parker LA Jr, Detterbeck FC, Egan TM (1999) Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy. Cancer 85: 1026
61. Ajani JA, Walsh G, Komaki R, Morris J (2004) Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction. Cancer 100: 2347
62. Swisher SG, Maish M, Erasmus JJ, Correa AM (2004) Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 78: 1152
63. Flamen P, Van Cutsem E, Lerut A et al. (2002) Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol 13: 361
64. Downey RJ, Akhurst T, Ilson D et al. (2003) Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol 21: 428
65. Wieder H, Brucher BL, Zimmermann F et al. (2004) Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 22: 900
66. Fan Z, Baselga J, Masui H, Mendelsohn J (1993) Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis- diammine-dichloroplatinum on well established A431 cell xenografts. Cancer Res 53: 4637
67. Brown D, Wang R, Russel P (2000) Antiepidermal growth factor receptor antibodies augment cytotoxicity of chemotherapeutic agents on squamous cell carcinoma cell lines. Otolaryngol Head Neck Surg 122: 75
68. Milas L, Mason K, Hunter N et al. (2000) In vivo enhancement of tumor radioresponse by C225 anti-epidermal growth factor receptor antibody. Clin Cancer Res 6: 701
69. Vrieze O, Haustermans K, De Wever W et al. (2004) Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma? Radiother Oncol 73: 269